Prof. Dana Wolf received her M.D. degree at the Hebrew University Hadassah Medical School, and completed her Internal Medicine residency and her Fellowship in Infectious Diseases at Hadassah Medical Center. She pursued a postdoctoral fellowship in Virology at the University of California San Diego, during which she also received her formal training in Diagnostic Virology at the California Department of Health Services in Berkley. She later worked as a visiting scientist at Stanford University. She is a Senior Physician in Infectious Diseases (since 1997) and the director of the Clinical Virology Unit at the Hadassah Medical Center (since 2001). She is the Chair of the Chanock cathedra in Virology at the Hebrew University.
Her studies have focused on human cytomegalovirs (HCMV) transmission and pathogenesis, the mechanism of HCMV antiviral drug resistance and its clinical impact, and the discovery and evaluation of novel antiviral drug targets. Employing original dynamic models of maternal–fetal viral transmission, her findings unveil the molecular events mediating the earliest stages of congenital HCMV infection, provide a mechanistic basis for the development of fetal disease, and pave the way to prenatal screening and prevention of congenital HCMV infection. Under her leadership, the Clinical Virology Unit at Hadassah has developed state-of-the-art assays for viral detection and has been recognized as a National WHO-collaboration center. Prof. Wolf has been recently awarded the Landau Prize for the Sciences and the Performing Arts in the field of Virology for “her achievements in translational research which facilitate clinical treatment strategies.”